O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
| Autor: | Knox, J., Bazin, I., Oh, D., Zubkov, O., Breder, V., Bai, L., Christie, A., McNamara, M., Goyal, L., Cosgrove, D., Springfeld, C., Sjoquist, K., Park, J., Verdaguer, H., Braconi, C., Ross, P., de Gramont, A., Shroff, R., Zalcberg, J., Palmer, D., Valle, J. |
|---|---|
| Zdroj: | In Annals of Oncology June 2023 34 Supplement 1:S180-S181 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|